These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

735 related articles for article (PubMed ID: 17579498)

  • 1. Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.
    Apud JA; Weinberger DR
    CNS Drugs; 2007; 21(7):535-57. PubMed ID: 17579498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia.
    Goldberg TE; Egan MF; Gscheidle T; Coppola R; Weickert T; Kolachana BS; Goldman D; Weinberger DR
    Arch Gen Psychiatry; 2003 Sep; 60(9):889-96. PubMed ID: 12963670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolcapone improves cognition and cortical information processing in normal human subjects.
    Apud JA; Mattay V; Chen J; Kolachana BS; Callicott JH; Rasetti R; Alce G; Iudicello JE; Akbar N; Egan MF; Goldberg TE; Weinberger DR
    Neuropsychopharmacology; 2007 May; 32(5):1011-20. PubMed ID: 17063156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of COMT (Val(108/158)Met) genotype and olanzapine treatment on prefrontal cortical function in patients with schizophrenia.
    Bertolino A; Caforio G; Blasi G; De Candia M; Latorre V; Petruzzella V; Altamura M; Nappi G; Papa S; Callicott JH; Mattay VS; Bellomo A; Scarabino T; Weinberger DR; Nardini M
    Am J Psychiatry; 2004 Oct; 161(10):1798-805. PubMed ID: 15465976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The catechol-O-methyltransferase (COMT) Val158Met genotype modulates working memory-related dorsolateral prefrontal response and performance in bipolar disorder.
    Miskowiak KW; Kjaerstad HL; Støttrup MM; Svendsen AM; Demant KM; Hoeffding LK; Werge TM; Burdick KE; Domschke K; Carvalho AF; Vieta E; Vinberg M; Kessing LV; Siebner HR; Macoveanu J
    Bipolar Disord; 2017 May; 19(3):214-224. PubMed ID: 28544426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prefrontal neurons and the genetics of schizophrenia.
    Weinberger DR; Egan MF; Bertolino A; Callicott JH; Mattay VS; Lipska BK; Berman KF; Goldberg TE
    Biol Psychiatry; 2001 Dec; 50(11):825-44. PubMed ID: 11743939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diverse facets of COMT: from a plausible predictive marker to a potential drug target for schizophrenia.
    Gupta M; Kaur H; Jajodia A; Jain S; Satyamoorthy K; Mukerji M; Thirthalli J; ; Kukreti R
    Curr Mol Med; 2011 Dec; 11(9):732-43. PubMed ID: 21999147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism.
    Giakoumaki SG; Roussos P; Bitsios P
    Neuropsychopharmacology; 2008 Dec; 33(13):3058-68. PubMed ID: 18536698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between catechol-O-methyltransferase (COMT) Val158Met genotype and genetic vulnerability to schizophrenia during explicit processing of aversive facial stimuli.
    Lo Bianco L; Blasi G; Taurisano P; Di Giorgio A; Ferrante F; Ursini G; Fazio L; Gelao B; Romano R; Papazacharias A; Caforio G; Sinibaldi L; Popolizio T; Bellantuono C; Bertolino A
    Psychol Med; 2013 Feb; 43(2):279-92. PubMed ID: 22617427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MTHFR 677C --> T genotype disrupts prefrontal function in schizophrenia through an interaction with COMT 158Val --> Met.
    Roffman JL; Gollub RL; Calhoun VD; Wassink TH; Weiss AP; Ho BC; White T; Clark VP; Fries J; Andreasen NC; Goff DC; Manoach DS
    Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17573-8. PubMed ID: 18988738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.
    Egan MF; Goldberg TE; Kolachana BS; Callicott JH; Mazzanti CM; Straub RE; Goldman D; Weinberger DR
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6917-22. PubMed ID: 11381111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COMT Val(158)Met genotype determines the direction of cognitive effects produced by catechol-O-methyltransferase inhibition.
    Farrell SM; Tunbridge EM; Braeutigam S; Harrison PJ
    Biol Psychiatry; 2012 Mar; 71(6):538-44. PubMed ID: 22364739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolcapone, COMT polymorphisms and pharmacogenomic treatment of schizophrenia.
    Bitsios P; Roussos P
    Pharmacogenomics; 2011 Apr; 12(4):559-66. PubMed ID: 21521027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catechol-O-methyltransferase, dopamine, and sleep-wake regulation.
    Dauvilliers Y; Tafti M; Landolt HP
    Sleep Med Rev; 2015 Aug; 22():47-53. PubMed ID: 25466290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications.
    Weickert TW; Goldberg TE; Mishara A; Apud JA; Kolachana BS; Egan MF; Weinberger DR
    Biol Psychiatry; 2004 Nov; 56(9):677-82. PubMed ID: 15522252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia.
    Woodward ND; Jayathilake K; Meltzer HY
    Schizophr Res; 2007 Feb; 90(1-3):86-96. PubMed ID: 17123785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of catechol-O-methyltransferase on prefrontal brain functioning in schizophrenia spectrum disorders.
    Ehlis AC; Reif A; Herrmann MJ; Lesch KP; Fallgatter AJ
    Neuropsychopharmacology; 2007 Jan; 32(1):162-70. PubMed ID: 16823382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of the catechol-O-methyltransferase Val158Met genotype on the cognitive function of schizophrenia patients and healthy Japanese individuals.
    Tsuchimine S; Yasui-Furukori N; Kaneda A; Kaneko S
    PLoS One; 2013; 8(11):e76763. PubMed ID: 24282499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of catechol-O-methyltransferase Val158Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia.
    Bosia M; Bechi M; Marino E; Anselmetti S; Poletti S; Cocchi F; Smeraldi E; Cavallaro R
    Neurosci Lett; 2007 May; 417(3):271-4. PubMed ID: 17383818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catechol-O-methyltransferase Val158Met polymorphism influences prefrontal executive function in early Parkinson's disease.
    Zhang Y; Feng S; Nie K; Zhao X; Gan R; Wang L; Zhao J; Tang H; Gao L; Zhu R; Wang L; Zhang Y
    J Neurol Sci; 2016 Oct; 369():347-353. PubMed ID: 27653922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.